Search results
MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com
ETF DAILY NEWS· 12 hours agoInvestment analysts at StockNews.com started coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a report issued on Wednesday. The firm set a “hold” rating on the biopharmaceutical ...
Unlocking the body’s defences: understanding immunotherapy
The Conversation· 1 day agoIt serves as a guardian, constantly patrolling the body to keep it safe from invaders like bacteria, viruses, and even cancer cells. Scientists are harnessing the power of the body’s natural ...
Sanofi boosts French biomanufacturing with €1 billion investment
Investing.com· 4 days agoSanofi (EPA: SASY ) (NASDAQ: SNY ), a global biopharmaceutical company, announced today a...
This Mother's Day, I'm celebrating the fact that I can bake with my kid again. Not long ago, that...
Business Insider· 5 days agoThis Mother's Day, I'm celebrating the fact that I can bake with my kid again. Some days, I'd push...
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoSangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript May 9, 2024 Sangamo...
Long Dismissed, Chronic Lyme Is Finally in the Spotlight
Time Magazine· 21 hours agoSue Gray, 59, has been sick half her life. When Gray was 30 and living with her then-husband in the...
Sketchy stem-cell treatments in Mexico led to drug-resistant infections
Live Science via Yahoo News· 4 days agoThe injections were reportedly intended to treat the autoimmune disease multiple sclerosis, for...
Vanda Pharmaceuticals Reports Mixed Q1 2024 Results, Misses Revenue Estimates
GuruFocus.com via Yahoo Finance· 7 days agoNotable among these is the FDA's recent approval of Fanapt for the treatment of acute bipolar I...
J&J to buy Proteologix and its dual-targeting antibody drugs for $850M
BioPharma Dive via Yahoo Finance· 1 day agoThe deal is part of a plan by J&J to build a portfolio of “differentiated” bispecific antibodies, an...
Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoRoyalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript May 9, 2024 Royalty Pharma plc...